https://www.selleckchem.com/pr....oducts/semaxanib-su5
This includes an overview and discussion of the various approaches to improve CAR-Treg specificity and therapeutic efficacy as well as addressing potential safety concerns. We also discuss different imaging approaches to understand the in vivo biodistribution of administered Tregs. Preclinical research as well as suitability of methodologies for clinical translation are discussed.Objectives The clinical outcome of bullous pemphigoid appears worse in patients with infectious complications, and assessment of the prevalence and ri
Mi piace
Commento
Condividi
